Log In
Print this Print this

Tysabri, natalizumab

Also known as: AN100226 (formerly Antegren)

  Manage Alerts
Collapse Summary General Information
Company Biogen Inc.
DescriptionHumanized mAb against integrin alpha(4)
Molecular Target Integrin alpha(4) (VLA-4 ) (CD49D)
Mechanism of ActionBinds integrin alpha(4); Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today